UKRI Call for Proposals: Joint Global Health Trial (Call 11 – trial development grants)
This scheme from the UK Research and Innovation (UKRI) untitled Joint Global Health Trials (Call 11 – trial development grants) seeks to support research that addresses the health problems affecting low and middle-income countries (LMICs) by funding definitive trials that are likely to produce implementable and generalisable results to change policy and practice.
- LMIC principal investigators may be based at higher education institutions or non-profit research institutions.
- UK principal investigators must be based at eligible UK research organisations.
- applications must include investigators based in the country/ies where the trial will take place.
The purpose of this scheme is to provide funding for the best proposals to generate new knowledge about interventions that will contribute to the improvement of health in low- and middle-income countries (LMICs). The scheme is focused on late-stage clinical and health intervention trials evaluating efficacy and effectiveness. The scheme remains primarily a mechanism to support definitive trials. However, it is recognised that preliminary work is often needed in order for applicants to develop innovative partnerships and trial proposals.
Who can apply?
This call is open to and particularly encourages applicants to apply from eligible research institutions based in low- and middle-income countries (LMICs) as well as the UK.
The scheme is targeted at trials led by academic groups, and not at trials led by commercial companies or product development partnerships (PDPs). However, applications are welcome from investigators from academic institutions who wish to collaborate with commercial companies or PDPs. Academic-industry collaborations will be considered under the MRC Industry Collaboration Agreement (MICA) mechanism.
Read more here.
Proposal deadline February 4, 2021.
